New approaches to flavivirus vaccine development.
Schlesinger
J J
JJ
Putnak
J R
JR
Eckels
K H
KH
D000818:Animals; D002213:Capsid / Q000276:immunology; D005416:Flavivirus / Q000276:immunology*; D006801:Humans; D051379:Mice; D011994:Recombinant Proteins / Q000276:immunology; D014036:Togaviridae Infections / Q000276:immunology / Q000517:prevention & control; D014614:Vaccines, Synthetic / Q000276:immunology; D014758:Viral Core Proteins / Q000276:immunology; D014759:Viral Envelope Proteins / Q000276:immunology; D017361:Viral Nonstructural Proteins; D014765:Viral Vaccines / Q000276:immunology*
D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; D017361:Viral Nonstructural Proteins; D014765:Viral Vaccines; C065696:glycoprotein E, Flavivirus